54 related articles for article (PubMed ID: 21386655)
21. Killer genes in pancreatic cancer therapy.
Fogar P; Greco E; Basso D; Navaglia F; Plebani M; Pedrazzoli S
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):61-76. PubMed ID: 16171565
[TBL] [Abstract][Full Text] [Related]
22. Systemic and local immunosuppression in pancreatic cancer patients.
von Bernstorff W; Voss M; Freichel S; Schmid A; Vogel I; Jöhnk C; Henne-Bruns D; Kremer B; Kalthoff H
Clin Cancer Res; 2001 Mar; 7(3 Suppl):925s-932s. PubMed ID: 11300493
[TBL] [Abstract][Full Text] [Related]
23. Pancreatic cancer shows modest survival gain.
Bankhead C
J Natl Cancer Inst; 1996 Jun; 88(12):784-6. PubMed ID: 8637040
[No Abstract] [Full Text] [Related]
24. Identification of thioredoxin-interacting protein 1 as a hypoxia-inducible factor 1alpha-induced gene in pancreatic cancer.
Baker AF; Koh MY; Williams RR; James B; Wang H; Tate WR; Gallegos A; Von Hoff DD; Han H; Powis G
Pancreas; 2008 Mar; 36(2):178-86. PubMed ID: 18376310
[TBL] [Abstract][Full Text] [Related]
25. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic.
Shi Q; Abbruzzese JL; Huang S; Fidler IJ; Xiong Q; Xie K
Clin Cancer Res; 1999 Nov; 5(11):3711-21. PubMed ID: 10589791
[TBL] [Abstract][Full Text] [Related]
26. Molecular basis of T cell-mediated recognition of pancreatic cancer cells.
Ito M; Shichijo S; Tsuda N; Ochi M; Harashima N; Saito N; Itoh K
Cancer Res; 2001 Mar; 61(5):2038-46. PubMed ID: 11280764
[TBL] [Abstract][Full Text] [Related]
27. Cancer gene profiling in pancreatic cancer.
Vilardell F; Iacobuzio-Donahue CA
Methods Mol Biol; 2010; 576():279-92. PubMed ID: 19882267
[TBL] [Abstract][Full Text] [Related]
28. [Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide].
Yang B; He Y; Sun DL; Zou Y; Qin XH; Huang BH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1956-60. PubMed ID: 19062734
[TBL] [Abstract][Full Text] [Related]
29. Ki-ras point mutation and p53 expression in human pancreatic cancer: a comparative study among Chinese, Japanese, and Western patients.
Dong M; Nio Y; Tamura K; Song MM; Guo KJ; Guo RX; Dong YT
Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):279-84. PubMed ID: 10750666
[TBL] [Abstract][Full Text] [Related]
30. Improving prognosis in pancreatic cancer-an uphill endeavor.
Jonnalagadda SS
Gastroenterology; 2004 Nov; 127(5):1636-7. PubMed ID: 15521032
[No Abstract] [Full Text] [Related]
31. National Pancreatic Cancer Project. Workshop on pancreatic tumor markers.
Kupchik HZ; Reisfeld RA; Go VL
Dig Dis Sci; 1982 Jan; 27(1):65-72. PubMed ID: 7067572
[No Abstract] [Full Text] [Related]
32. Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer.
Loos M; Giese NA; Kleeff J; Giese T; Gaida MM; Bergmann F; Laschinger M; W Büchler M; Friess H
Cancer Lett; 2008 Sep; 268(1):98-109. PubMed ID: 18486325
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis.
Gansauge S; Gansauge F; Ramadani M; Stobbe H; Rau B; Harada N; Beger HG
Cancer Res; 1997 May; 57(9):1634-7. PubMed ID: 9134998
[TBL] [Abstract][Full Text] [Related]
34. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis.
Song B; Ju J
Expert Rev Mol Med; 2010 Oct; 12():e33. PubMed ID: 20942990
[TBL] [Abstract][Full Text] [Related]
35. Lymphocytes and pancreatic cancer: the effects of these cells on diagnosis and patient survival.
Pezzilli R; Fabbri D; Imbrogno A
JOP; 2011 Mar; 12(2):209-10. PubMed ID: 21386655
[No Abstract] [Full Text] [Related]
36. Gene-expression profiling in pancreatic cancer.
López-Casas PP; López-Fernández LA
Expert Rev Mol Diagn; 2010 Jul; 10(5):591-601. PubMed ID: 20629509
[TBL] [Abstract][Full Text] [Related]
37. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
Zhang Y; Dang C; Ma Q; Shimahara Y
Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]